Pancreatic cancer immune landscape reveals opportunities for personalized therapies

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies.

NIH officials used personal emails, tweaked words to skirt FOIA searches during pandemic, lawmakers find

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

May 29, 2024

Balanced breakfasts improve heart and metabolic health in older adults

Older adults with metabolic syndrome consuming either low- or high-energy breakfasts or low-quality breakfasts faced higher triglycerides, increased body fat, and worse kidney function. Breakfasts

December 16, 2024

MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT) | Psychedelic Invest

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat mental health disorders, today

July 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.